Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHICL Infrastructure Regulatory News (HICL)

Share Price Information for HICL Infrastructure (HICL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 122.20
Bid: 121.80
Ask: 122.20
Change: 0.60 (0.49%)
Spread: 0.40 (0.328%)
Open: 121.00
High: 122.60
Low: 121.00
Prev. Close: 121.60
HICL Live PriceLast checked at -
HICL Infrastructure is an Investment Trust

To deliver a long-term, stable income to shareholders from a diversified portfolio of infrastructure investments positioned at the lower end of the risk spectrum.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Equity Issue

22 Mar 2017 07:00

RNS Number : 1423A
HICL Infrastructure Company Ld
22 March 2017
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION, RELEASE, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN, OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL OR TO U.S. PERSONS. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE INCLUDING IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR TO U.S. PERSONS.

 

 

HICL Infrastructure Company Limited

 

Result of Placing, Open Offer, Offer for Subscription and Intermediaries Offer of New Ordinary Shares

22 March 2017

 

 

Highlights

 

- The fundraising undertaken pursuant to the Placing, Open Offer, Offer for Subscription and Intermediaries Offer has been successfully completed, with gross proceeds of £260 million raised. This represents the maximum amount permitted to be raised under the Issue, exceeding the target size of £205 million

 

- The Issue was very significantly oversubscribed, with applications totalling almost three times the number of Shares available under the Issue at its maximum size. Basic entitlements under the Open Offer will be met in full, with all other applications to be scaled back

 

- Proceeds of the Issue will be used to repay outstanding borrowings under the Facility, and to secure further investment opportunities identified by the Investment Adviser

Commenting on today's announcement, Ian Russell, Chairman of the Company, said:

"The Board of HICL is delighted to have had such a positive response to the Company's fundraising from both existing shareholders and new investors. The application of the Issue proceeds towards the elimination of the Group's funding requirement leaves the Company well-placed to fund further suitable additions to the portfolio.

Based on the Investment Adviser's confidence in the near-term investment pipeline, the Board elected to issue New Ordinary Shares for the maximum amount of £260 million permitted under the terms of the Issue. The strong appetite from investors for the Company's equity was reflected in the large number of applications that could not be accommodated in full. Nonetheless, this is encouraging in light of our stated acquisition strategy, and the attractive pipeline of investment opportunities the Investment Adviser is currently working on, some of which may materialise as new investments in due course."

 

The Board of HICL Infrastructure Company Limited ("HICL") is pleased to announce that the Placing, Open Offer, Offer for Subscription and Intermediaries Offer of New Ordinary Shares (the "Issue") has now closed and that, on the basis of applications received through the Open Offer, the Offer for Subscription and the Intermediaries Offer and of orders taken through the Placing, both the Issue's target size of 128,930,818 Ordinary Shares (raising gross proceeds of £205 million) and its maximum potential size of 163,522,013 Ordinary Shares (raising gross proceeds of £260 million) have been comfortably exceeded. The number of new Ordinary Shares in respect of which applications were made totalled almost three times the number of Shares available under the Issue at its maximum size.

The Board has consulted with the Investment Adviser, InfraRed Capital Partners Limited, on the Additional Investments which would allow the size of the Issue to be increased. As a result, the Board has decided that the overall size of the Issue will be set at its maximum of 163,522,013 New Ordinary Shares.

A total of 163,522,013 Shares will therefore be issued at a price of 159.0 pence per Share, of which 66,315,621 Shares will be issued pursuant to the Open Offer (including the Excess Application Facility), 8,905,372 Shares will be issued pursuant to the Offer for Subscription and the Intermediaries Offer, and 88,301,020 Shares will be issued under the Placing.

In accordance with the terms and conditions of the Issue, all applications made pursuant to Open Offer entitlements will be met in full. The Board has, in conjunction with its advisers, considered and determined the basis upon which applications made pursuant to the Placing, the Offer for Subscription and the Excess Application Facility should be scaled back given the high level of oversubscription in respect of the Issue.

Application has been made for the new Ordinary Shares to be admitted to the Official List of the UK Listing Authority and to trading on the Main Market of the London Stock Exchange. It is expected that Admission in respect of the new Ordinary Shares will become effective, and that dealings in the new Ordinary Shares will commence, at 8.00 a.m. on 24 March 2017.

The International Security Identification Number for the Shares is GG00B0T4LH64 and the TIDM is HICL.

Canaccord Genuity Limited acted as Placing Agent.

 

Expected Timetable

Admission to the Official List and commencement of dealings in New Ordinary Shares

 

8.00 a.m. on 24 March

 

Expected date for crediting of New Ordinary Shares to CREST accounts in uncertificated form

 

As soon as possible on 24 March

 

Expected date of despatch of definitive share certificates for New Ordinary Shares in certificated form

 

31 March

 

Enquiries

For further information, please contact: 

InfraRed Capital Partners Limited

Tony Roper

Keith Pickard

Harry Seekings

 

+44 (0) 20 7484 1800

Canaccord Genuity Limited

David Yovichic

Denis Flanagan

Robbie Robertson

 

+44 (0) 20 7523 8000

Tulchan Communications

David Allchurch

Latika Shah

 

+44 (0) 20 7353 4200

Terms in this announcement shall have the same meaning as defined in the prospectus issued by HICL dated 23 February 2017.

Important Information

 

This Announcement contains Inside Information as defined under the Market Abuse Regulation (EU) No. 596/2014.

This Announcement has been issued by and is the sole responsibility of the Company.

This Announcement is for information purposes only and does not constitute an invitation to subscribe for or otherwise acquire or dispose of securities in the Company in any jurisdiction. The information contained in this Announcement is for background purposes only and does not purport to be full or complete. This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase any investments nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

No representation or warranty express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by Canaccord Genuity Limited or by any of its respective affiliates or agents as to or in relation to, the accuracy or completeness of this Announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefore is expressly disclaimed.

This Announcement and the information contained herein is not for publication, release or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan or South Africa or any jurisdiction in which the same would be unlawful. This announcement does not constitute an offer to sell or issue or the solicitation of an offer to buy or acquire shares in the capital of the Company in the United States, Australia, Canada, Japan or South Africa or any jurisdiction in which such an offer or solicitation is unlawful.

Shares in the Company have not been, nor will be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or with any securities regulatory authority of any State or other jurisdiction of the United States, and accordingly may not be offered, sold or transferred within the United States except pursuant to an exemption from, or in a transaction not subject to, registration under the Securities Act. The Company has not been and will not be registered under the U.S. Investment Company Act of 1940, as amended (the "Investment Company Act") and investors will not be entitled to the benefits of that Act. In addition, relevant clearances have not been, and will not be, obtained from the securities commission (or equivalent) of any province of Australia, Canada, Japan or South Africa and, accordingly, unless an exemption under any relevant legislation or regulations is applicable, none of the Ordinary Shares or the New Ordinary Shares may be offered, sold, renounced, transferred or delivered, directly or indirectly, in Australia, Canada, Japan or South Africa.

Canaccord Genuity Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting for the Company and is acting for no-one else in connection with the Issue.

InfraRed Capital Partners Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, acts as Investment Adviser to the Company and is acting for no-one else in connection with the Issue.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROIOKDDKCBKDBNB
Date   Source Headline
16th Apr 20187:25 amRNSNew Investment
16th Apr 20187:25 amRNSNotice of Annual Results
5th Apr 20183:00 pmRNSDirector/PDMR Shareholding
29th Mar 201812:00 pmRNSTotal Voting Rights
26th Mar 20185:00 pmRNSDirector/PDMR Shareholding
26th Mar 20185:00 pmRNSDirector/PDMR Shareholding
26th Mar 20185:00 pmRNSDirector/PDMR Shareholding
26th Mar 201812:00 pmRNSAdditional Listing
26th Mar 20187:00 amRNSIncremental Investment
21st Mar 20185:02 pmRNSDirector/PDMR Shareholding
19th Mar 20182:43 pmRNSDirector Declaration
8th Mar 20185:30 pmRNSScrip Share Reference Price
2nd Mar 20182:00 pmRNSDirector/PDMR Shareholding
21st Feb 201812:52 pmRNSThird Quarterly Interim Dividend
7th Feb 201811:36 amRNSCapital Markets Seminar
5th Feb 20187:00 amRNSInterim Update Statement
1st Feb 20187:00 amRNSRenewal of the Group's Revolving Credit Facility
30th Jan 20188:00 amRNSDirector/PDMR Shareholding
29th Jan 20185:05 pmRNSDirector/PDMR Shareholding
29th Jan 20182:20 pmRNSDirector/PDMR Shareholding
29th Jan 20182:19 pmRNSDirector/PDMR Shareholding
26th Jan 20185:12 pmRNSDirector/PDMR Shareholding
26th Jan 20185:10 pmRNSDirector/PDMR Shareholding
26th Jan 20183:54 pmRNSDirector/PDMR Shareholding
26th Jan 20183:53 pmRNSDirector/PDMR Shareholding
26th Jan 20187:00 amRNSUpdate on Service Provision
15th Jan 20188:55 amRNSService Provision Continuity
3rd Jan 20183:00 pmRNSDirector/PDMR Shareholding
29th Dec 20171:30 pmRNSTotal Voting Rights
22nd Dec 201710:22 amRNSAdditional Listing
21st Dec 20175:00 pmRNSPublication of Interim Report
20th Dec 201711:00 amRNSKey Information Document
30th Nov 20173:00 pmRNSScrip Share Reference Price
27th Nov 20177:00 amRNSDirector/PDMR Shareholding
22nd Nov 20177:00 amRNSInterim Results Six Months Ended 30 September 2017
16th Nov 20177:00 amRNSSecond Quarterly Interim Dividend
4th Oct 20177:00 amRNSDirector/PDMR Shareholding 30 September 2017
29th Sep 20173:00 pmRNSTotal Voting Rights
26th Sep 20172:30 pmRNSAdditional Listing
14th Sep 20175:31 pmRNSHolding(s) in Company
7th Sep 20177:00 amRNSCompletion of Acquisition
1st Sep 20172:11 pmRNSScrip Share Reference Price
26th Jul 20178:25 amRNSPreferred Bidder Announcement
24th Jul 20177:00 amRNSInterim Update Statement
21st Jul 20173:00 pmRNSScrip Dividend Circular
18th Jul 20173:33 pmRNSFirst Quarterly Interim Dividend
14th Jul 20172:50 pmRNSAcquisition
5th Jul 20173:40 pmRNSDirector/PDMR Shareholding
3rd Jul 20175:38 pmRNSTotal Voting Rights
22nd Jun 20172:00 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.